Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.37 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16133790 | 0.94 | CYP3A4 (0.39) | CYP3A4CYP2C8KCNH2 | |
| SCHEMBL18809153 | 0.88 | CNR1 (0.37) | CNR1CNR2BCHE | |
| SCHEMBL16133764 | 0.86 | CYP3A4 (0.37) | CYP3A4CYP2C8 | |
| SCHEMBL18809160 | 0.86 | CYP3A4 (0.38) | CYP3A4CYP2C8KCNH2 | |
| SCHEMBL16133808 | 0.81 | CYP3A4 (0.42) | CNR2CYP3A4CYP2C8KCNH2 | |
| SCHEMBL16133789 | 0.81 | CYP3A4 (0.36) | CYP3A4CYP2C8 | |
| SCHEMBL18038609 | 0.79 | ANO1 (0.42) | CYP3A4CYP2C8KCNH2 | |
| SCHEMBL18038576 | 0.79 | CYP3A4 (0.40) | CYP3A4CYP2C8KCNH2 | |
| SCHEMBL19806163 | 0.79 | CYP3A4 (0.41) | CYP3A4CYP2C8KCNH2 | |
| SCHEMBL18038598 | 0.79 | ANO1 (0.43) | CYP3A4CYP2C8KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970174-B1 | FUSED FURANS FOR THE TREATMENT OF HEPATITIS C | BRISTOL MYERS SQUIBB CO (US) | 2017-05-03 | — | — | EP | disclosed |